HOME >> MEDICINE >> NEWS
Measuring certain enzyme activity in urine shows promise for detection of bladder cancer

Measurement of an enzyme level (telomerase activity) in urine appears useful for detection of bladder cancer in men, according to a study in the October 26 issue of JAMA.

The incidence of human bladder cancer has greatly increased over the last few decades, with more than 60,000 new cases diagnosed each year in the United States alone, and now represents the 4th most common malignancy in men and the 10th most common in women, according to background information in the article. At present, about 20 percent of patients die each year, but when the disease is diagnosed and treated in the early stage, the chances of survival are good, indicating the importance of a timely and accurate diagnosis.

Established approaches for detecting bladder cancer are either invasive and costly or have limited sensitivity, highlighting the need for the development of a noninvasive, reliable, and simple test to increase the rate of detection of bladder cancer. Among the markers investigated for this purpose has been telomerase (a certain enzyme) activity in urine.

Maria Aurora Sanchini, M.Sc., of Morgagni-Pierantoni Hospital, Forl, Italy, and colleagues conducted a study to define the diagnostic accuracy of different telomerase activity cutoff values in terms of sensitivity and specificity. The study included 218 men (84 healthy individuals and 134 patients at first diagnosis of histologically confirmed bladder cancer), recruited between March 2003 and November 2004 in Italy. Urine telomerase activity was determined using a highly sensitive telomeric repeat amplification protocol (TRAP) assay. Urine samples were processed for cytological (cell) diagnosis and TRAP assay. The diagnosis of bladder cancer was based on bioptic and cystoscopic examinations (direct visual examination of the urinary tract). The performance of the TRAP assay to detect urine telomerase activity was compared to urine cytology as an aid to early cancer detection.

Using a 50 arbitrary e
'"/>

Contact: Daniele Calistri, Ph.D.
biomolec@ausl.fo.it
JAMA and Archives Journals
25-Oct-2005


Page: 1 2 3

Related medicine news :

1. Measuring lung motion leads to better radiation treatment for lung cancer
2. Measuring brain activity for emotional markers that may indicate risk for developing alcoholism
3. Measuring proteins in spinal fluid may provide early clue to Alzheimers disease
4. Measuring artery repair cells could become new heart disease test
5. Measuring hormone cuts antibiotic use in half in pneumonia patients
6. Measuring enzymes at end of cancer pathway predicts outcome of Tarceva, Taxol
7. Antifolate therapies found effective against certain type of malaria
8. Low-glycemic load diet may be more effective for dieters with certain insulin response patterns
9. No increased risk of certain cancers from electromagnetic fields among energy workers
10. Concentrations of certain toxins in breast milk are low, study finds
11. Improved adherence to certain medications associated with longer survival following heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... August 07, 2020 , ... On August 4, the ... rule for the 2021 calendar year. The proposal significantly impacts hip and knee ... which help return patients suffering from joint disease to productive, pain-free lives. , ...
(Date:8/5/2020)... ... August 05, 2020 , ... In its often-heroic ongoing ... challenges. Regardless of the obstacle - shortages of tests, ventilators and ICU beds; ... cancellation or postponement of all nonessential services - providers across the country have ...
(Date:8/5/2020)... ... August 05, 2020 , ... Today, YPO Africa , a global ... investment platform for Africa, announced that they have entered into a unique bilateral alliance. ... to support each other in their African impact efforts, with an initial focus on ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... today the launch of its newest product, CoverageCoach. The site provides a simple ... and purchase insurance products. The company sees CoverageCoach as an important expansion for ...
(Date:7/31/2020)... ... July 31, 2020 , ... ... plans, is announcing an expansion of clinical & technical capabilities to cover the ... most complete back and joint health solution. , Currently, employers interested in ...
Breaking Medicine News(10 mins):
(Date:7/22/2020)... ... July 22, 2020 , ... ... top healthcare companies and part of WPP (NYSE:WPP), has continued its investment in ... , As the agency ventures further into healthcare consumer media, Warren will be ...
(Date:7/10/2020)... ... 10, 2020 , ... Precision ADM, Inc. (“Precision ADM” or ... announced that their CANSWAB™ nasopharyngeal swabs are the first Canadian-made COVID-19 testing product ... swab design and has trademarked the name CANSWAB™ for distribution. The collection capability ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... The Urgent ... Control and Prevention (CDC) are collaborating to present a virtual education on acute flaccid ... webinar will take place at 1 p.m. CT on July 14, 2020. , ...
Breaking Medicine Technology:
Cached News: